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Abstract
Background: As a rule, peptides are more flexible and unstructured than proteins with their
substantial stabilizing hydrophobic cores. Nevertheless, a few stably folding peptides have been
discovered. This raises the question whether there may be more such peptides that are unknown
as yet. These molecules could be helpful in basic research and medicine.
Results: As a method to explore the space of conformationally stable peptides, we have developed
an evolutionary algorithm that allows optimization of sequences with respect to several criteria
simultaneously, for instance stability, accessibility of arbitrary parts of the peptide, etc. In a proof-
of-concept experiment we have perturbed the sequence of the peptide Villin Headpiece, known to
be stable in vitro. Starting from the perturbed sequence we applied our algorithm to optimize
peptide stability and accessibility of a loop. Unexpectedly, two clusters of sequences were
generated in this way that, according to our criteria, should form structures with higher stability
than the wild-type. The structures in one of the clusters possess a fold that markedly differs from
the native fold of Villin Headpiece. One of the mutants predicted to be stable was selected for
synthesis, its molecular 3D-structure was characterized by nuclear magnetic resonance
spectroscopy, and its stability was measured by circular dichroism. Predicted structure and stability
were in good agreement with experiment. Eight other sequences and structures, including five with
a non-native fold are provided as bona fide predictions.
Conclusion: The results suggest that much more conformationally stable peptides may exist than
are known so far, and that small fold classes could comprise well-separated sub-folds.
Background
Until a few years ago it was widely believed that peptides
of chain lengths well below 50 residues are conformation-
ally highly flexible or even disordered, whereas the longer
polypeptide chains of proteins form stable native confor-
mations ([1], p. 189; [2], p. 95). The latter seemed natural
as native conformations are mainly stabilized by hydro-
phobic cores, and proteins can have a much higher ratio
of core volume to total size than small peptides. (Note
that many short peptides are known that are stabilized by
disulfide bridges or metal ions; here we focus on peptides
without such intra-chain bonds.)
Over the last years the traditional belief had to give way to
a more differentiated picture: it was found that peptides
can show a pronounced propensity for adopting a signifi-
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there have been examples of peptides with stable and
well-defined tertiary structures [7] or [8]. Remarkably,
although the latter peptides have native conformations,
they are not just smaller versions of typically multi-func-
tional proteins but either designed peptides (Trp-cage [8],
20 residues), or derived from single protein domains (Vil-
lin Headpiece [7], 36 residues), or they have no functions
that require interaction with different specific molecules
(antifreeze protein AFP I [9], 37 residues). Hence, it is
plausible to assume that the observed rough correlation of
larger size and well-defined conformation of proteins is
not so much a consequence of elementary biophysics but
of biological evolution in environments rich in specific
functional interactions. Evolution may have selected mol-
ecules with numerous different and well-defined surface
patches for specific functional interactions, and the neces-
sity of harboring many such well-defined patches on the
same molecule naturally leads to larger, conformationally
stable polypeptides. Therefore, by ignoring such biologi-
cal effects and concentrating on physical feasibility one
can expect that it is possible to identify or design many
more peptides that fold into stable native structures in the
huge sequence space of 20 to 40 residues.
For biotechnology and medicine such peptides would be
interesting tools [10,11]. In these disciplines it is often
aspired to have a molecule with a single specific function,
and this could be realized with molecules much smaller
than a typical protein. Smaller molecules potentially also
have better bioavailability, are less immunogenic and
cheaper. An illustrative example is the design of small
peptide mimotopes, i.e. peptides that mimic a large pro-
tein antigen by presenting just the epitope interacting
with the antibody. In this case we require that the
designed peptide is optimized with respect to several
objectives simultaneously, e.g. small size, conformational
stability, and presentation of the epitope in its native form
and accessibility. The conventional way of solving such a
problem is the definition of a scalar fitness function that
combines these objectives, e.g. as a linear combination of
single objectives. However, such combinations are notori-
ously problematic because the functional form of the fit-
ness is usually unknown. A typical case is the use of
experimental data (constraints from NMR experiments or
X-diffraction data) and classical force field in the refine-
ment of biomolecular structures. There, one usually com-
bines experimental constraints and force field to a
pseudo-energy. Often the functional form of this pseudo-
energy is assumed to be a linear combination of the two
terms with the weights determined from practical experi-
ence. If such a form is not known, the multitude of objec-
tives cannot be combined to a single scalar objective
function. A way to circumvent this problem is inferential
structure determination [12,13] where simulation data is
used to probabilistically rank possible solutions, though
not to drive an optimization. Multi-objective- or Pareto-
optimization could be applied there as an alternative. The
fundamental difference between single-and multi-objec-
tive optimization is that the set of optima in general is
much larger for the latter method as it allows for a flexible
trade-off between the various objectives [14]. Practically,
this means that during a single-objective optimization
one often has only one optimum (which can be relatively
arbitrary due to the choice of the objective function),
whereas multi-objective methods usually forwards a
whole set of optima, the Pareto-front (see Additional file
1). For the optimization of molecules Pareto-methods are
currently addressed by several groups [15-17], though
most of these researchers focus on the optimization of
small molecules that do not adopt stable native confor-
mations.
We have developed an algorithm for the optimization of
realistic peptide models [18] of conformationally stable
peptides. Briefly, the algorithm comprises the following
five steps: (1) an optional step of transplanting a given
epitope onto suitable carrier peptides of known 3D-struc-
ture; (2) automated modeling of several point mutants
using as templates the energetically most favorable or oth-
erwise fittest peptides of the parent generation; (3) the
molecular dynamics (MD) of each point mutant in aque-
ous solution is simulated over a time of the order of 10 ns
with a classical all-atom force field in explicit solvent; (4)
extraction of fitness values from each trajectory; (5) selec-
tion of fittest individuals. The algorithm iterates over steps
(2)-(5) an arbitrary number of times. To test algorithm
and model we proposed the following computational
experiment [18]: First a sequence of the well-characterized
conformationally stable peptide Villin Headpiece (VH)
[7] was perturbed by a point mutation that is expected to
strongly destabilize the native VH structure by destroying
its small hydrophobic core. If we subject this mutated
peptide to our optimization algorithm with objective
functions chosen to be compatible with the native struc-
ture (stability, native accessibility of some epitope loop),
then the algorithm could recover the more stable native
sequence of VH. In fact, the algorithm generated several
mutants that, according to our computational results,
should be even more stable than wild-type VH. As an
example we have recently identified in silico the point
mutant G34L [18].
Here we investigate how the algorithm explores the space
spanned by amino acid sequences and the two objective
functions global stability and accessibility of an epitope
loop. To this end we analyze data from the sequence per-
turbation experiment introduced above, where we had
performed two evolutionary optimization runs. Our
results suggest that there could indeed be a considerablePage 2 of 13
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may, in addition, fulfill other functionally related criteria.
We present in vitro data on the structure and stability of
the G34L mutant, where we find good agreement between
computational prediction and experimental test.
Results
Evolutionary optimization
We have perturbed the sequence of VH by mutation F18K
(note that we number residues in VH from 1 to 36, in
deviation from the numbering scheme used in PDB entry
1vii [19], e.g. F18 in the present work corresponds to F58
in [19]). F18 stabilizes the native conformation, and even
a relatively conservative mutation such as F18L destabi-
lizes the fold [20]. We have introduced F18K, a much
more drastic mutation that replaces the bulky hydropho-
bic side chain of Phe by the long, flexible, and positively
charged side chain of Lys. Visual inspection of the wild-
type 3D-structure [19] suggested that mutation F18K
should strongly destabilize the native fold as it removes
the phenyl ring of F18 from the small hydrophobic core
of the peptide and replaces it by the positively charged
side chain of Lys with no compensating negative charge
nearby. In fact, in a MD simulation the mutant structure
fell apart quickly.
Starting from F18K, the peptide sequence was then opti-
mized with respect to two objective functions (see Eqs. 1
and 2 in Methods section): (1) the conformational stabil-
ity σ of the peptide, (2) a quantity α related to the solvent
accessible surface of an "epitope loop" comprising resi-
dues 12–17. These two objectives were chosen because
they capture peptide properties that are often desired in
practical applications. Specifically, maximization of con-
formational stability σ is important as it improves resist-
ance against peptidases, and leads to well defined binding
sites and thus lower entropical penalties on binding. In
contrast to σ, which quantifies a global feature of a pep-
tide, the objective function α describes a local aspect of
the binding site, namely the negative root mean square
deviation (RMSD) of residue-wise solvent accessible sur-
faces along the epitope loop between some target confor-
mation and the peptide conformations generated in the
course of the evolutionary optimization. (For α the nega-
tive RMSD value is used for convenience as it allows to
treat the optimization of α as maximization, too.) Maxi-
mization of α is necessary to make sure that the binding
face is exposed to a putative binding partner to the same
extent as in a target conformation. Note that maximiza-
tion of α will in general not be sufficient to drive the
epitope loop towards some target conformation; this
could be achieved by introducing a conformational
RMSD of the epitope loop as third objective function. In
this proof-of-concept study we have restricted the number
of objective functions to two in order to facilitate data
analysis.
Pareto-optimization should maximize both objective
functions simultaneously towards their theoretical maxi-
mum values of σmax = 1 and αmax = 0, respectively. This
maximization is effected by using Pareto-dominance [14]
as fitness criterion in the evolutionary optimization: The
fitness values of non-dominated peptides are higher than
those of dominated peptides. (A peptide i generated in the
course of the optimization is said to strictly dominate a
peptide j if σ(i) > σ(j) ^ α(i) > α(j).)
The two evolutionary optimization runs started from the
same F18K mutant structure modeled in silico but with dif-
ferent random seeds. In each of the runs we produced 15
generations of peptides, each generation comprising 8
individual sequences and their respective structures. As
evolutionary operation solely point mutations were
applied to peptide sequences of the previous generation,
so that the maximum number of sequence differences
generated in the runs is 15 with respect to the initial F18K
mutant, or 16 to the wild-type VH. Due to the costly fit-
ness function the total computational expense was of the
order of 1 year of CPU time.
The dynamics of the peptides in sequence space is visual-
ized in Fig. 1 and Fig. 2 by showing the percentage π(i, j)
of identities in optimal sequence pair alignments between
any two sequences i, j generated in run 1 (Fig. 1) and 2
(Fig. 2). The maximum value of π(i, j) is 100 and means
that both sequences are identical. The theoretical mini-
mum value of 0 cannot be reached because of the con-
served epitope loop (see also Methods section).
It can be seen in Fig. 1 and Fig. 2 that both runs start from
a set of highly similar sequences. However, then the devel-
opment becomes distinct between the runs.
In run 1 the population becomes slowly and steadily more
diverse. In generation 15 at the end of the run π varies
between about 40 and 100 within that generation (square
at upper right corner of Fig. 1), which means that the
sequences within that generation can differ at up to 22
sequence positions. With respect to the initial sequence,
the sequences have π values of about 65 to 75 (square in
lower right or upper left of Fig. 1), corresponding to about
13 to 9 mutations. Hence, the population seems to spread
out from the initial sequence in different directions in
sequence space.
In run 2 diversity first develops more quickly and culmi-
nates in generation 6. Towards the end of the run the
intra-generation diversity decreases again to π values of
above 90, with one outlier individual having a π ofPage 3 of 13
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15. Remarkably, the intra-generation diversity at both
start and end are low (lower left and upper right corners),
while the difference between first and last generation are
higher (lower right corner). This means that after 15 gen-
erations the whole population has settled in a region of
sequence space different from the initial region. Overall,
in the second run p remains in a more narrow range
between about 65 and 100.
The evolution in sequence space described above is the
result of point mutations and selections according to
Pareto-dominance with respect to σ and α. Consequently,
the Pareto-front defined by the non-dominated individu-
als shifts to the right to higher values of α, and upwards to
the maximum σ = 1 in both runs (see also figures 5 and 6
in Additional file 1).
The data from objective functions and sequence space is
summarized in Fig. 3. It displays (α, σ) values of all indi-
viduals from both runs and simultaneously, indicated by
the plot symbols, the numbers of mutations with respect
to the native VH sequence. The figure refers back to the
initial hypothesis that there may exist many more pep-
tides that fulfill certain criteria, including conformational
stability. In fact, the figure shows that there are about a
dozen sequences with 1 to 9 mutations and σ ≈ 1, and that
some of these also have α values of up to -50 (the runs
actually generate 19 times individuals with σ = 1, but
some of these are identical, so that there remain 12 differ-
ent individuals).
Figure 3 has several other interesting features. The major-
ity of individuals from both runs cluster at low σ values in
the bottom part of the plot. The ranges of α values from
both runs are wide and overlapping. This broad distribu-
tion is not astonishing for the following reason. We have
computed α using the sampled conformation of lowest
energy of the individual peptide, and for low values of the
stability σ this single conformation (and hence its α) can
be rather arbitrary. This means that for low σ values we
must expect a noisy distribution of α.
The picture changes above about σ = 0.5. In a transition
region of σ values between about 0.7 and 0.9, the density
of individuals is reduced, and a gap opens between α val-
ues of -80 and -70. For high σ values the density increases
again while the gap along the α axis persists, so that for
Percentage identities of sequences in run 2Figure 2
Percentage identities of sequences in run 2. Percent-
age identities of sequences in run 2. Analogous to Fig. 1, note 
however that the range of percentage identity values is nar-
rower than in run 1.
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Percentage identities π(i, j) of sequences in run 1Figure 1
Percentage identities π(i, j) of sequences in run 1. All 
sequences i and j of individuals in run 1 are compared with 
respect to pairwise sequence identity. As there are 15 gener-
ations (15 bins along each axis of the plot), each with 8 indi-
viduals (8 stripes in each bin), there are 15·8 = 120 
sequences and 1202 comparisons, corresponding to the ele-
ments of the symmetric matrix in the figure. The legend at 
the right side of the plot shows the color coding of the π val-
ues (see also Methods section).
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groups with α < -80 and α > -70, respectively.
The fact that in Fig. 3 there is an accumulation of individ-
uals at high σ values seems to support our initial hypoth-
esis. Note that it is not possible to conclude from the
number of points in a certain region of the (α, σ) plane to
numbers of individual peptides in that region, because
sequences may have been sampled several times. How-
ever, the correction for this multi-sampling does not affect
the overall picture (see Additional file 1 for details).
After the correction, there are nine sequences with a σ
value of exactly 1, i.e. they form stable conformations
according to the criterion described in the Methods sec-
tion. These nine individuals are the most interesting
members of the Pareto-front since they promise not only
high stability but also well-defined structure and surface
exposure of the epitope loop. Five of these individuals
come from run 1 and in Fig. 3 are located right of the α
gap (α > -70). Of the remaining four stable individuals,
three are from run 2 and one is from run 1; all four indi-
viduals in Fig. 3 are left of the α gap (α < -75). We have
compared these nine individuals with respect to sequence
and structure, including in the comparison also the wild-
type VH sequence and structure as tenth individual; all ten
individuals are provided as supplementary material
(Additional file 2).
All ten sequences are shown in a multiple sequence align-
ment in Fig. 4. The alignment shows that the sequences
can be roughly grouped in two clusters, a non-native one
(sequences 1–5), and a native one (sequences 6–10) that
includes wildtype VH (sequence 6). The main features dis-
tinguishing non-native and native cluster cluster are A vs.
D at position 4, E vs. W at position 24, and as largest dif-
ference a strictly conserved AYW motif at 32–34 in the
non-native cluster that replaces a motif with consensus
sequence EKG in the native cluster. Another notable fea-
ture concerns the initial perturbation K18: most of the
sequences retain this K, especially all sequences in the
non-native cluster.
Fig. 5 shows quantitatively by pairwise comparisons that
the individuals not only cluster in sequence space, but
also show the same clustering in terms of 3D-structure.
The two clusters are clearly separated with Cα RMSD val-
ues of below 3Å within each cluster and 6–8Å between the
clusters. Overall, sequences follow an analogous pattern
(right part of Fig. 5), though one of the individuals
(number 10) from the native VH cluster has a sequence
that seems to be roughly equidistant to both clusters in
sequence space.
The two clusters correlate perfectly with the two groups
left and right of the α gap, respectively, in Fig. 3, with the
native cluster on the left and the non-native cluster on the
right of the gap. It may be surprising that the α-values in
the native-like cluster are lower than those in the non-
native cluster. The reason for this is that the reference
structure for the computation of α according to Eq. 1 is the
experimental native structure [19] and not the native
structure relaxed in force field simulations without exper-
imental constraints. This relaxation leads to a shift of α in
the native cluster to values below -75. Accordingly, the
structures left of the α gap with α values around -80 have
structures similar to the relaxed native VH structure.
The other cluster (individuals 1–5 in Fig. 4 and Fig. 5) is
remarkable since it combines maximum σ, increased α
values, and non-native structure. The superposition with
the native VH fold in Fig. 6 shows that in the non-native
cluster the N-terminal helix is tilted, the middle helix is
almost dissolved into a number of turns, the C-terminal
helix is shortened and tilted, and the C-terminal loop
moves into the core. Nevertheless, as visible in Fig. 6, the
global topology of the new fold is still related to that of
the native VH. Hence, it may be appropriate to speak of
the two clusters as of two sub-folds of the VH fold.
Stabilities and accessibilities of all individualsFigure 3
Stabilities and accessibilities of all individuals. Stability 
and accessibility values of all individuals from run 1 (black) 
and run 2 (red). Plot symbols indicate numbers of mutations 
of individuals with respect to wild-type VH (characters a, b, 
and c correspond to mutation numbers 10, 11, and 12, 
resp.). The maximum number of mutations is 12 in run 1 and 
9 in run 2.
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ized C-terminal loop, the A32Y33W34 sequence feature
mentioned above, and K18. In fact the internalized part
mainly comprises this AYW motif and allows the forma-
tion of a hydrophobic cluster integrating also the aliphatic
part of the sidechain of K18. The amino-tip of the latter is
always exposed to the solvent, while in most of the non-
native structures, the aliphatic part of K18 forms a broad
contact with the aromatic ring of Y33 (see also Fig. 7 in
Additional file 1).
Sequence alignment of stable individualsFig re 4
Sequence alignment of stable individuals. Multiple alignment of sequences of high-σ individuals from Fig. 5 (same number-
ing of sequences). The code ragbic on the left shows that sequence comes from run a ∈ {1, 2}, generation b ∈ {1, 2, ..., 15}, indi-
vidual c ∈ {0, 1, ..., 7}. 1vii is the wild-type sequence. Different colors in an alignment column are used to emphasize that the 
column is occupied by two different residues. Boxes separate residues that are in the minority in an alignment column from the 
majority. Figure prepared using Prettyplot [43].
5 10 15 20 25 30 35
Pairwise comparison of stable individualsFigure 5
Pairwise comparison of stable individuals. Pairwise comparison of all sequences with highest stability (σ = 1) and wild-
type VH (individual 6) with respect to structure (left) and sequence (right). The left panel shows the pairwise RMSD with 
respect to Cα-positions after optimal superposition; color codes RMSD in units of 1 Å (= 0.1 nm). The right panel gives the per-
centage sequence identity between the same peptides as on the left (using same numbering of individuals as there). The figure 
shows that the individuals fall into two clusters or sub-folds, a cluster with modified fold and sequences (individuals 1–5) and a 
cluster similar to the wild-type (individuals 6–10).Page 6 of 13
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gration of the C-terminal loop into the core is the move of
the N-terminus (see Fig. 6). In the native fold, the position
of the N-terminus may be stabilized by a salt-bridge
between D4 and R15. The Cβ-distance lies at 4–5 Å in our
models, and our experimental data (see below) supports
that the locations of both sidechains allow a salt-bridge.
As described above, we have in all non-native sequences
at position 4 an Alanine so that a salt-bridge to R15 is no
longer possible. This should facilitate large rearrange-
ments of positions 4 and 15 without energetic penalties.
This is consistent with the observed increase of the Cβ-dis-
tance between residues 4 and 15 to 15–18 Å in the non-
native fold models (see also Fig. 8 in Additional file 1).
After this large shift, the N-terminus forms part of clamp
into which the C-terminal loop is embedded (Fig. 6).
The third sequence feature that distinguishes native and
non-native individuals is W vs. E at position 24. The
native W24 has been found experimentally to be impor-
tant for interaction of VH with its natural binding partner
F-actin [21]. Visual inspection of the native structure of
VH or the models of its homologs gives no indications
why the structure of VH alone should be stabilized by
W24. On the other hand does inspection of our non-
native models suggest that E24 could stabilize the short α-
helix comprising residues 23–28 by providing a capping
interaction [22] with the N-terminus of this helix. This
helix is also present in the natively folded models, and the
fact that we do not see native models with E24 may be due
to the stochastic nature of the sampling procedure.
There are also two structures in the native cluster (individ-
uals 8 and 10) that have retained K18. They have found a
surprisingly simple solution of how to accommodate this
residue without changing the fold. The sidechain of K18 is
bent sharply so that this aliphatic turn roughly takes the
place of the phenyl-ring of the native F18 in the hydro-
phobic core, while the amino group is again exposed at
the surface (see also Fig. 8 in Additional file 1).
The first structure with σ = 1 that we have encountered in
our study was indeed a revertant (individual number 7 in
Fig. 4) that reintroduced the native F18; but even this indi-
vidual differs from the wild-type VH by mutation G34L. It
had been reported in Ref. [18] that the wild-type VH
according to our stability criterion is quite stable but does
not reach σ = 1. In contrast, individual 7 has σ = 1, and
thus promised to have a higher stability while leaving the
fold native. This prediction – native fold with higher sta-
bility – has prompted our first experimental test. Results
of this test are given in the experimental section below.
Experimental results: 3D-structure and stability
The first peptide with σ = 1 generated in the evolutionary
optimization was the point mutant G34L of wild-type VH.
Amongst all 39 single and double mutants only two (cor-
responding to 5%) had this stability. In Fig. 3 G34L can be
easily identified since it is the only individual from run 1
in the group with σ = 1 and α < -75. In Fig. 4 and Fig. 5 it
corresponds to individual number 7. According to the
simulation the peptide belongs to the native VH sub-fold
but has a higher stability than the native VH. To test these
predictions we have carried out an experimental three-
dimensional NMR structure determination together with
denaturation experiments monitored by CD spectros-
copy. Details are given below and in the experimental part
of the Methods section.
For NMR structure determination, a total of 388 NOE dis-
tance restraints obtained from the 2D NOESY spectrum
were used in the final structure calculations. These were
distributed as 193 intra-residual restraints, 142 sequential
restraints, 42 medium-range restraints (|i - j| ≤ 4), and 29
Superposition of representatives from the two stable sub-foldsFigu e 6
Superposition of representatives from the two stable 
sub-folds. Superposition of native VH (green) and sixfold 
mutant r1g11i0 (cyan). The two structures have been super-
imposed optimally with respect to their Cα positions (RMSD 
5.9 Å) using the Kabsch-algorithm [44]. The arrow marks the 
shift of the C-terminus.Page 7 of 13
(page number not for citation purposes)
BMC Bioinformatics 2008, 9:109 http://www.biomedcentral.com/1471-2105/9/109long-range restraints (|i - j| > 4). In addition, 24 Φ and 24
Ψ angle restraints were obtained from an analysis of the
1H secondary chemical shifts. Based on these experimen-
tal restraints, structures were calculated using a simulated
annealing protocol in the program CNS [23] and the best
structures in terms of total energy were selected for further
analysis. In agreement with the prediction, the analysis of
the experimentally solved structures shows that the mole-
cule folds into one stable globular domain that consists of
three α-helices. Helices H1, H2 and H3 comprise residues
Asp4 to Phe11, Arg15 to Ala19, and Leu23 to Glu32,
respectively. Fig. 7A shows the experimental structure pos-
sessing the lowest total energy in a ribbon representation.
An overlay of five of the final solution structures is shown
in Fig. 7B. In the set of ten selected final solution struc-
tures the average RMSD value to the mean structure
amounts to 1.7 Å for the Cα atoms. The experimental
structure with the lowest total energy is compared in Fig.
7C with the predicted structure shown in green. The aver-
age pairwise RMSD value between the model structure
and the ten selected final NMR structures is 2.9 Å. It is
clear that both model and experimental NMR structure
display the same global fold, while minor differences can
be observed for the regular secondary structure elements;
especially the second α-helix has a slightly different orien-
tation in the model structure compared to the NMR struc-
tures.
One reliable way to test the agreement between experi-
mental data and a three-dimensional structure is to back-
calculate the experimental data from the trial structure
and then to compare simulated and experimental data.
We have been using for this purpose the AUREMOL mod-
ule RELAX [24-26]. To check the agreement of our model
structure with the experimental 2D NOESY spectrum, its
spectrum was back-calculated based on the predicted
structure of G34L and the experimental resonance line
assignment. As an example two corresponding sections of
these spectra are displayed in Fig. 8A with the experimen-
tal spectrum on the left and the simulated spectrum on
the right. Both sections correspond to the N-terminal
amino acids Ser3, Asp4, and Phe7. The two sections are
virtually identical indicating that the model structure fits
the experimental data very well for these residues. In gen-
eral the comparison of the experimental and simulated
data indicates similarly to the comparison of the corre-
sponding structures that the predicted structure is fairly
close to the experimental data. However, it should be
noted that the results also indicate that the orientations of
several side-chains such as Phe 11 differ between model
and experimental data (Fig. 8B) for example in the simu-
lated spectrum an interaction between HB3 18 and HD 11
is visible while this interaction is missing in the experi-
mental spectrum. In this context, one has to consider that
even the stable peptides with σ = 1 still can have some
conformational flexibility, especially in the less well
ordered loop regions, and what one observes in solution
with NMR spectroscopy is an ensemble average. A single
model structure as it was used for the data simulation can
only represent one of many possible sub-states present in
solution. Recently a high resolution X-ray structure of the
wild-type VH has been published [27]. In Fig. 7D the pre-
dicted structure (green) is compared to both the X-ray
structure (blue) and the best NMR structure in terms of
total energy (red). Obviously, all three molecules adopt
the same three-dimensional fold, and the limits of the reg-
ular secondary structure elements are almost identical.
The stability of the peptide was experimentally deter-
mined from GuHCl denaturation experiments monitored
with CD spectroscopy. Fig. 9 shows the linear extrapola-
tion of the ΔG values determined in the transition region
to 0 M GuHCl, giving a value of 18.2 kJ/mol. To allow a
comparison with previously obtained data for the corre-
sponding wild-type peptide, measurements were per-
formed under similar conditions and also similar
Comparisons of experimental and predicted structuresFigure 7
Comparisons of experimental and predicted struc-
tures. Experimentally solved solution NMR structure of the 
VH mutant G34L (deposited in PDB, code 2ppz). (A) Ribbon 
diagram of the lowest energy structure in terms of total 
energy. (B) Overlay of 5 final solution structures. (C) Com-
parison between the model structure (green) and the lowest 
energy experimental structure. (D) Comparison between the 
model structure (green), the wild-type X-ray structure (blue) 
and the lowest energy experimental structure.
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ously [7].
The experimentally determined ΔG value of 18.2 kJ/mol
(4.3 kcal/mol) for the VH-mutant G34L is similar to the
previously determined ΔG values of 3.3 and 4.1 kcal/mol
obtained in H2O and D2O, respectively, for the wild-type
peptide [7].
Our experimental data on structure and stability indicate
that the in silico predictions are essentially correct with
respect to the G34L mutant, namely that the structure of
the peptide is not perturbed by this mutation but rather
stabilized.
Discussion
We have presented results on evolutionary in silico optimi-
zation of peptides with respect to two objective functions,
including conformational stability. The optimization
method is conceptually simple but computationally
demanding due to the detailed modeling of the biomo-
lecular system with classical all-atom force fields. This
level of detail was chosen to allow for direct comparison
with experiment, as shown above.
Despite the fact that classical force fields have proven their
usefulness in numerous applications, they are not perfect.
As we are performing extended molecular dynamics sim-
ulations, imperfections of the force field model may well
influence conformational distributions [28]. Moreover,
our simple single molecule model does neglect other fac-
tors that are important in experiments, such as the pro-
pensity to aggregate. Nevertheless, we think that the
model is sufficiently peptide-like to allow conclusions
from evolutionary optimization runs to real peptides.
Experimental stabilityFigu e 9
Experimental stability. GuHCl unfolding of the Villin 
Headpiece mutant G34L as monitored by CD spectroscopy. 
Shown is the linear extrapolation of the ΔG values deter-
mined in the transition region to 0 M GuHCl.
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Comparison of experimental and simulated spectraFigure 8
Comparison of experimental and simulated spectra. 
(A) Section corresponding to residues 3, 4, and 7 of the 
experimental 2D NOESY spectrum of the VH mutant G34L. 
Right: The corresponding region of the simulated spectrum. 
Simulations were performed using the predicted structure. 
(B) A different region is cut out of the whole spectrum. Again 
in general both regions agree well. However, the signal cor-
responding to HB3 18/HD 11 is visible in the simulated spec-
trum on the right side while it is completely missing in the 
experimental one, indicating for this region a different side-
chain orientation between prediction and true solution 
structure.Page 9 of 13
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BMC Bioinformatics 2008, 9:109 http://www.biomedcentral.com/1471-2105/9/109With the high computational demands of the molecular
model, efficiency is an important aspect. In view of the
wide spread and seemingly erratic movements of objec-
tive function values (see Additional file 1) one may ask
whether a simple random sampling of mutations may
have led to similar results. We have tested this and found
a maximum stability of 0.32 in such runs, i.e. with the
same use of CPU time, random single mutations did not
generate any stable individual (see Additional file 1).
Given the large size of sequence space, this is not surpris-
ing and does not contradict our hypothesis that there exist
many islands of stability. We think that these islands are
probably surrounded by a much larger sea of instability.
This picture was also one of the reasons why we have
avoided more complex evolutionary operators such as
cross-over that potentially permit hopping between
islands. The other reason was that the larger changes
brought about by these operators would be difficult to
relax during molecular dynamics simulations of accepta-
ble lengths. However, we are exploring other options, e.g.
double mutations with their potential to mutually com-
pensate deleterious effects on stability while changing
other fitness terms of the molecule.
A point to consider is the danger of generating individuals
that are kinetically trapped in meta-stable conformations.
We think that the fact that we see stability in both native
and non-native group, each comprising four to five indi-
viduals, tested for stability in as many independent simu-
lations, backs the assertion that these conformations are
not kinetically trapped. This has been further supported
by several longer independent MD simulations in which
the predicted structures have remained stable. Neverthe-
less, we will analyse their energy landscape further with
suitable methods [29] and try to determine their struc-
tures in vitro.
The results evoke new questions, for instance whether the
sub-folds are necessarily isolated or whether there may
exist bridges between some of them. Optimization algo-
Algorithm for evolutionary optimizationFi u e 10
Algorithm for evolutionary optimization. Flow chart of evolutionary optimization used in present study.
max. no. of 
generations
exceeded?
selectionpopulation
− specification of objectives
− initial sequence
start:
archive
end
no
3. amino acid exchange probabilities
4. choice of amino acid
2. choice of mutation site
1. mutation site probabilities
    − accessibility
    − .....
fitness evaluation:
mutation:
1. molecular dynamics simulation
2. computation of objective values
    − stability
yesPage 10 of 13
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BMC Bioinformatics 2008, 9:109 http://www.biomedcentral.com/1471-2105/9/109rithms such as the presented one could also be applied to
find peptides that switch between sub-folds, depending
on temperature, pH, or other conditions.
Conclusion
For the exploration of sequence-structure space of pep-
tides we have used evolutionary Pareto-optimization,
exploring sequence space with point mutations and eval-
uating proposed sequences with a computationally inten-
sive, realistic model. A first in vitro test of computational
results has supported the viability of the method. The
application of the method to a perturbed sequence of the
conformationally stable Villin Headpiece peptide gener-
ated two clearly distinguishable, stably folding clusters or
sub-folds of peptides, each populated by several
sequences: a native Villin Headpiece sub-fold, and a dis-
torted sub-fold with a similar global topology. Since it is
unlikely that Villin Headpiece is the only stable peptide
that follows this pattern, we conclude that sub-folds could
be a common fine-structure of the peptide fold-space, and
that many undiscovered stably folding peptides may exist.
Methods
Evolutionary optimization
For the in silico optimization, a multi-objective evolution-
ary algorithm has been used. The algorithm has been
described in detail in [18]. Hence, we here repeat only the
key elements of it (see Fig. 10). Point mutations were used
as sole evolutionary operator to move through sequence
space. Mutations were preferentially introduced at posi-
tions where they promised to be stabilizing; mutations
were performed with Whatif [30]. To identify such posi-
tions we carried out computational alanine scanning for
each new individual. At those positions where mutation
to Ala led to the largest stabilization we introduced all
possible amino acids and chose one of these randomly
according to probabilities proportional to their predicted
stabilizing effect; stabilization was computed by combin-
ing force field energies [31] and solvation energies [32].
The fitness of each new offspring individual was evaluated
on the basis of a 10 ns molecular dynamics simulation
with Gromacs 3.2 [31]. Individuals for the next generation
were selected from the pool of the previous generation
and its direct offsprings in a tournament using Pareto-
dominance together with elitism [14,16] in the (α, σ)
plane of objective functions (see below) as selection crite-
rion. In more detail, in each tournament at first two indi-
viduals from the pool of parents and offsprings were
chosen at random. Secondly, the two individuals were
compared with respect to Pareto-dominance. If one of the
individuals dominated the other individual the former
was transferred to the next generation; if not, one of the
two individuals was chosen at random. The first step, i.e.
the random choice of a pair for the tournament is a mech-
anism to preserve diversity in the pool, while the second
step prefers fitter individuals. Despite this preference, the
random choice of pairs may lead to the extinction of the
fittest individuals. In order to avoid this we used elitism,
i.e. the best individuals generated during the optimization
process were stored in an archive of fixed size to preserve
individuals with top fitness; in each new generation, a
fraction of these individuals was fed back from the
archive.
Two objective functions were used, α and σ. The α value
of an individual is defined as root mean square deviation
(RMSD) solvent accessible surfaces (SAS) between resi-
dues on a target peptide and an individual peptide gener-
ated in the course of the optimization. This RMSD value is
not computed for the whole peptide, but restricted to an
"epitope" region:
with the number Nep of residues in the arbitrarily selected
epitope (here the six residues 12–17 with sequence
GMTRSA); the sum running over all residues j in the
epitope; SAS(i, j) the SAS (in Å 2) of residue j in the indi-
vidual i generated in the course of the simulation; SAS(0,
j) the corresponding surface of j in the target conforma-
tion (here: native wild-type conformation). SAS values
were computed with naccess [33]. The maximum value of
α is 0 in which case the epitope has the same residue-wise
accessibilities in both the target and the individual confor-
mation. The maximum value of α ≈ -50 observed in the
optimization runs corresponds to a difference between
native and individual SAS of about the SAS of a single car-
bonyl oxygen atom.
The second objective function, σ, is defined as the fraction
of conformations in a trajectory with a Cα-RMSD to the
initial conformation of that trajectory below a threshold
ρmax:
with Nsteps the number of steps stored from a molecular
dynamics trajectory; ρ0,i the Cα-RMSD between the initial
and the ith conformation stored from a trajectory; ρmax has
been set to 3.5 Å as a result of previous analyses of molec-
ular dynamics simulations of stable peptides; δ = 1 if the
parenthesized argument is true and δ = 0 if it is false. If all
recorded conformations in a molecular dynamics trajec-
tory are close to the initial conformation, σ can reach its
a( ) ( ( , ) ( , ))i
Nep
SAS i j SAS j
j
Nep
= − −
=
∑1 0 122
1 Å
(1)
s d r r= <
=
∑1 0
1
N steps
i max
i
N steps
( ), (2)Page 11 of 13
(page number not for citation purposes)
BMC Bioinformatics 2008, 9:109 http://www.biomedcentral.com/1471-2105/9/109maximum value of 1, and the peptide can be considered
conformationally stable.
The percentage π(i, j) of identities between two sequences
i, j was computed from a multiple sequence alignment of
all ten sequences shown in Fig. 4 with ClustalW [34]. For
the progressive pairwise alignment step in ClustalW the
following options were used: Needleman-Wunsch algo-
rithm, Gonnet matrix, gap opening and extension penal-
ties of 10 and 0.1, respectively. π values refer to the full
sequence length of 36. Since the epitope loop 12–17 is
not mutated, p values shown in Fig. 1 and Fig. 2 have a
constant baseline at 16.7.
Most analyses in the computational part have been carried
out with R [35], including the bio3d package [36]. Figures
showing molecular structures were prepared using
PyMOL [37].
Peptide synthesis
The VH mutant G34L was synthesized on a MultiSynTec
SYRO peptide synthesizer.
NMR spectroscopy
For the NMR measurements 4.3 mg of the peptide were
dissolved in 0.5 ml of 90%/10% (v/v) H2O/D2O and 0.1
mM 2,2-dimethyl-2-silapentane sulfonic acid (DSS) for
internal referencing. The pH was adjusted to 5.0. NMR
experiments were carried out at 298 K on a BRUKER DRX
500 MHz spectrometer equipped with three channels and
a pulsed-field gradient triple-resonance probe equipped
with z-gradients. The sequence-specific 1H resonance line
assignment was performed using 2D TOCSY and NOESY
spectra employing mixing times of 80 and 250 ms, respec-
tively. NOE distance restraints were obtained from 2D
NOESY spectra measured in H2O using a mixing time of
250 ms. Processing of the 2D data sets was accomplished
using the Bruker software XWINMR while automated and
manual spectra analysis was performed employing the
software package AUREMOL [38].
Structure calculations
Structure calculations were performed using the program
CNS 1.1 [23] and a dynamic simulated annealing proto-
col for extended-strand starting structures. The Φ and Ψ
angle restraints were obtained from an analysis of the pro-
ton chemical shifts using the program TALOS
2003.027.13.05 [39]. Accurate distance constraints were
obtained from the NOE spectra by using the full relaxa-
tion matrix approach embedded in the AUREMOL mod-
ule RELAX/REFINE (to be published). Appropriate
individual error bounds were obtained by a local analysis
of noise levels and signal overlap. In total 200 structures
were calculated of which the 10 best in terms of total
energy were selected for further analysis.
Structure analysis
Secondary structure elements and RMSD values were cal-
culated with the program MOLMOL 2K.2 [40] and struc-
tures were further analysed with PROCHECK v.3.4.4 [41].
CD spectroscopy
Circular dichroism spectra were measured in an AVIV
62A-DS spectropolarimeter. For CD spectroscopy 20 μg
peptide was dissolved in 150 mM NaCl, 25 mM acetate
and varying amounts of GuHCl at pH 5.0. For the guani-
dine hydrochloride (GuHCl) denaturation experiments
15 samples were prepared containing 0.0, 1.0, 1.5, 2.0,
2.5, 3.0, 3.5, 4.0, 4.5, 5.0, 5.5, 6.0, 6.5, 7.0, and 8.0 M
GuHCl, respectively. Samples were equilibrated for 12
hours at 4°C. CD data were collected at 222 nm in a 5 mm
path-length cell. For each step the average of 6 data points
measured at an interval of 2 s was calculated. Data were
baseline corrected by subtraction of a buffer-only experi-
ment. The ΔG value at 0 M GuHCl was obtained by linear
extrapolation of the ΔG values determined in the transi-
tion region [42].
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